A new Alzheimer’s drug has recently undergone clinical trials and has successfully reduced a plaque-like substance known to be present in the brains of patients who suffer from the disease. A pharmaceutical research company, known as Merck, has produced and tested a new drug called Verubecestat. A trial designed to […]
